Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2021-08-31 01:30Genentech pulls breast cancer drug after FDA questions accelerated approval and more...
2021-08-30 01:30Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021
2021-08-29 01:30Astra Conducts Test Launch and more...
2021-08-28 01:30Bayer Berkeley campus development plan includes focus on career opportunities and more...
2021-08-27 01:30Kevin Judice rolls South San Francisco biotech Dice toward a $100M IPO and more...
2021-08-26 01:30Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development and more...
2021-08-25 01:30Biondo Biondi: How to measure an earthquake through the internet and more...
2021-08-24 01:30Theravance Biopharma, Inc. Announces Top-line Results from Phase 2b Dose-Finding Induction Study of Izencitinib in Patients with Ulcerative Colitis and more...
2021-08-22 01:30Energy Secretary Jennifer Granholm visits Berkeley Lab
2021-08-21 01:30After stalling in the U.S., FibroGen anemia drug wins European nod and $120M partner payout and more...
2021-08-20 01:30Food allergy drug developer bites into Philadelphia-area manufacturing and more...
2021-08-19 01:30Q&A: Microbes and life on other planets and more...
2021-08-18 01:30Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet and more...
2021-08-17 01:30CohBar Appoints Carol Nast to Its Board of Directors and more...
2021-08-16 01:30Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction ...
2021-08-14 01:30Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update and more...
2021-08-13 01:30Nkarta Reports Second Quarter 2021 Financial Results and Business Progress and more...
2021-08-12 01:30Atreca Reports Second Quarter 2021 Financial Results and Recent Corporate Developments and more...
2021-08-11 01:30Rakuten Medical Announces Two New Members to Board of Directors, Appoints Nitin Nohria as Chairman of the Board and more...
2021-08-10 01:30Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference and more...
2021-08-09 01:30Innovent Announces the Establishment of the Scientific Advisory Board
2021-08-07 01:3010x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit and more...
2021-08-06 01:30Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology and more...
2021-08-05 01:30Denali Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights and more...
2021-08-04 01:30Genentech requiring Covid vaccination for workforce and more...
2021-08-03 01:30How artificial neural networks help us understand neural networks in the human brain and more...
2021-08-01 01:30IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語